← All companies
HALO annual net income
HALOZYME THERAPEUTICS, INC.
HALO - CIK 0001159036
Market cap$8.36 B
Rank#1040
SEC filings1,481
HALOZYME THERAPEUTICS, INC. net income by year
HALOZYME THERAPEUTICS, INC. (HALO) reported net income of $316.89M for fiscal year 2025, as filed in its audited annual report with the SEC.
HALO net income 2011-2025
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $316.89M | -28.6% |
| FY 2024 | $444.09M | +57.7% |
| FY 2023 | $281.59M | +39.3% |
| FY 2022 | $202.13M | -49.8% |
| FY 2021 | $402.71M | +212.0% |
| FY 2020 | $129.09M | +278.7% |
| FY 2019 | -$72.24M | +10.1% |
| FY 2018 | -$80.33M | -227.6% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does HALOZYME THERAPEUTICS, INC. make?
HALOZYME THERAPEUTICS, INC. (HALO) reported net income of $316.89M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has HALOZYME THERAPEUTICS, INC.'s net income changed over time?
Between fiscal 2011 and fiscal 2025, HALOZYME THERAPEUTICS, INC.'s net income grew from -$19.77M to $316.89M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.